The healthcare market has been one of the economy’s fastest growing sectors, not only since the COVID-19 pandemic. This also applies to corporate finance and M&A transactions. The number of investments in digital health and AI-related applications is growing particularly strongly (Corporate Finance, 2020). Similarly, venture capital and private equity transactions in biopharmaceuticals and health tech are on the rise, both in terms of the number and size of deals. (Deloitte, 2020).
Corporate Law & Corporate Finance
The healthcare market has been one of the economy’s fastest growing sectors, not only since the COVID-19 pandemic.
Corporate Law (Corporate/M&A)
In the field of corporate law (Corporate/M&A), we advise German and international corporations, medium-sized companies, financial investors, securities issuers, investment platforms as well as fast-growing young companies in the following areas:
- Corporate Finance
- M&A
- Venture capital/private equity
- Capital market law including digital investments
Venture Capital
In the area of venture capital as well as capital markets law:
- Prospectus law (EU Securities Prospectus Regulation)
- German Capital Investment Act
- Law governing financial investment brokerage and investment advice (Section 1 German Banking Act, Financial Investment Brokerage Ordinance)
- Crowdfunding (e.g., proposal for the adoption of an EU Regulation for European Crowdfunding Service Providers (ECSP)).
In addition, we have been providing pro bono support for numerous start-up topics for years and are acting as lecturers for various university and government-funded incubators and accelerators.
Commercial ContractsCompliance
Corporate Law & Corporate Finance
Digital HealtheHealth & Medical AppsMedical CannabisProduct LiabilityProtection of IP RightsRegulation
